Skip to Main Content

There’s more money sloshing around in biotech than ever before.

Over the past year, several trends have converged to create a historic financing environment for startups, full of what industry insiders call “dry powder.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!